The aim of this paper was to address the entire range of morbidities as early in the course of the disease as is possible with the current data. The data were based on PD diagnoses from the Danish National Patient Registry (NPR). Methods Subject selection All patient hospital contacts in Denmark are recorded in the NPR by type and date of contact. The NPR includes administrative

information, primary and secondary diagnoses, diagnostic procedures, and treatment procedures using the International Inhibitors,research,lifescience,medical Classification of Diseases (ICD-10) and their date. Specific clinical information, such as the UPDRS score and imaging results, is not present in the NPR. The NPR contains diagnoses from private Inhibitors,research,lifescience,medical and public hospitals, but does not record diagnoses from general practice. Using the NPR, we identified all patients at least 20 years of age who were diagnosed with PD between 1997 and 2007. For

the PD diagnoses, we used the code G20.9. The code G20 is not accepted in the NPR, so all PD patients are registered as G20.9 (Paralysis agitans). Hospital doctors report the NPR at the time of diagnosis. Then, using data from Denmark’s Civil Registration System Statistics, we randomly selected citizens of the same age, gender, and marital status as the patients who did not have PD. Parity Inhibitors,research,lifescience,medical of socioeconomic status (SES) was ensured by selecting control subjects from the same part of the country as where the patient lived. The ratio of control subjects to

patients was 4:1. Data from patients and matched control subjects who could not be identified in the Coherent Inhibitors,research,lifescience,medical Social Statistics database were excluded from the sample. More than 99% of the observations in the two groups were successfully matched. Morbidity data from the patients and matched control subjects were gathered from their year of Inhibitors,research,lifescience,medical diagnosis until 2007. Data selleck chemicals llc analysis Data were analyzed by developing a conditional logit model, where the dependent variable was the case–control group and the explanatory variables were dummies for the 21 major ICD10 diagnosis groups, omitting the group with no diagnosis 3 years before diagnosis. A second analysis included dummies for ICD10 diagnosis that occurred in more than 1% of either the case or control group. ICD10 diagnoses accounting for 1% or fewer of the total diagnoses were included in the main diagnosis groups. Only estimates for the ICD10 diagnoses are reported in the results, but the dummies for Batimastat the main groups (including the then remaining diagnoses) were included in the regression. Patients could be classified in more than one diagnostic group or with an ICD10 diagnosis during the 3 years before the diagnosis. Not all patients had a 3-year observation period before the registered diagnosis; for the first 3 years of the period, the patient only had data for 1 or 2 years, but as this was also the case for the control group, we have included these shorter periods in the analysis.